You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Characteristics of patients studied

From: Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy

  N (%) Mean ± SD Median (Range)
Age   57.62 ± 12.9 60 (30-83)
   <60 years 12 (46.2)   
   ≥60 years 14 (53.8)   
Menopause    
   Premenopausal 8 (30.8)   
   Postmenopausal 18 (69.2)   
Tumor type    
   Inflammatory 7 (26.9)   
   Non-inflammatory 19 (73.1)   
Tumor size    
   T3 1 (3.8)   
   T4a-T4b 18 (69.2)   
   T4c-T4d 7 (27.0)   
Nodes    
   N0 18 (69.2)   
   N1-N2 8 (30.8)   
Metastasis    
   M0 24 (92.3)   
   M1 2 (7.7)   
Bra size   100 ± 10.6 100 (80-120)
   <100 9 (34.6)   
   ≥100 17 (65.4)   
Systemic treatment    
   Chemotherapy 4 (15.4)   
   Hormonal therapy 5 (19.2)   
   Chemotherapy-hormonal therapy 17 (65.4)   
Received dose (Gy)   78.48 ± 5.7 81.60 (64.8-81.6)
   <81.6 7 (26.9)   
   ≥81.6 19 (73.1)   
Maximum dose (Gy)   87.36 ± 8.8 89.76 (62.8-101.7)
   <89.8 15 (57.7)   
   ≥89.8 11 (42.3)